Compound Description
| ID: C0276 | Common name: Oxycodone |
| IUPAC: (4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one | CAS: CAS:76-42-6 |
| Chembl ID: CHEMBL656 | Pubchem ID: CID:5284603 |
| Formula: C18H21NO4 | TCM-ID: TCMC1816 |
| Smiles: COc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@]4(O)CCC1=O)C | |
| Alias:
Codeinone, 7,8-dihydro-14-hydroxy-;
Morphinan-6-one, 4,5α-epoxy-14-hydroxy-3-methoxy-17-methyl-; (5α)-4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one; (-)-Oxycodone; 14-Hydroxydihydrocodeinone; 3-O-(Methyl)oxymorphone; 4,5α-Epoxy-14-hydroxy-3-methoxy-17-methyl-6-morphinanone; 6-Oxo-14-hydroxy-7,8-dihydrocodeine; 7,8-Dihydro-14-hydroxycodeinone; Dihydro-14-hydroxycodeinone; Dihydrohydroxycodeinone; Dihydrone; NSC 19043; Oxicon; Oxycodeinone; Oxycodone; Oxycodone DETERx; Oxymorphone 3-methyl ether; Oxynorm; PTI 821; Pavinal; Remoxy; Xtampza ER |
Structure:
|
Related Targets (Total: 4)
| Target id | Protein Name | Gene Symbol | Uniprot ID | Target Level | No.of Literature Evidence |
|---|---|---|---|---|---|
| T66YJ0 | Mu-type opioid receptor | OPRM1 |
P35372 |
A | 3 Reference(s) |
| T43DMF | Kappa-type opioid receptor | OPRK1 |
P41145 |
A | 1 Reference(s) |
| T23VMI | Tumor necrosis factor | TNF |
P01375 |
C | 1 Reference(s) |
| T79KQO | NF-kappa-B inhibitor alpha | NFKBIA |
P25963 |
C | 1 Reference(s) |
*In this table, target level represents the quality confidence indicators of targets.
Level 'A' represents "Directly inhibit/activate".
Level 'B' represents "Indirectly inhibit/ activate", "Enzyme substate" and "Enzyme product".
Level 'C' represents "Up/Down regulation" and "Others".
Level 'A' represents "Directly inhibit/activate".
Level 'B' represents "Indirectly inhibit/ activate", "Enzyme substate" and "Enzyme product".
Level 'C' represents "Up/Down regulation" and "Others".
Related Herbs (Total: 3)
Ckey description of the interaction between compound and target